- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Torii Pharmaceutical Co Ltd (4551)
Torii Pharmaceutical Co Ltd stock price live, this page displays TYO 4551 stock exchange data. View the 4551 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Torii Pharmaceutical Co Ltd real time stock price chart below.
What Is the Torii Pharmaceutical Co Ltd Stock Price Today?
The Torii Pharmaceutical Co Ltd stock price today is 6,330.0.
What Is the Stock Symbol for Torii Pharmaceutical Co Ltd?
The stock symbol for Torii Pharmaceutical Co Ltd is ""4551.""
What Stock Exchange Does Torii Pharmaceutical Co Ltd Trade On?
Torii Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Torii Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Torii Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4551 quote. (ISIN: JP3635800000)
What Is the Torii Pharmaceutical Co Ltd Stock Price Today?
The Torii Pharmaceutical Co Ltd stock price today is 6,330.0.
What Is the Stock Symbol for Torii Pharmaceutical Co Ltd?
The stock symbol for Torii Pharmaceutical Co Ltd is ""4551.""
What Stock Exchange Does Torii Pharmaceutical Co Ltd Trade On?
Torii Pharmaceutical Co Ltd is listed and trades on the Tokyo stock exchange.
Is Torii Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Torii Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 4551 quote. (ISIN: JP3635800000)
Tokyo
Currency in JPY
6,330.0
+10.0(+0.16%)
Delayed Data·
Fair Value
An estimate of a Torii Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,320.0
6,330.0
52 wk Range
3,105.0
6,420.0
4551 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Earnings results expected in 8 days
More Info
Fair Value
An estimate of a Torii Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,320.06,330.0
52 wk Range
3,105.06,420.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.90%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
4551 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Torii Pharmaceutical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
4,200.0
Downside
-33.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy
Torii Pharmaceutical Co Ltd Company Profile
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents for renal diseases and hemodialysis, such as ENAROY tablets to treat anemia associated with CKD; Riona tablets for the treatment of hyperphosphatemia/iron deficiency anemia (IDA); and REMITCH, an oral therapeutic agent for the treatment of pruritus. The company provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; CORECTIM, a topical janus kinase (JAK) inhibitor; VTAMA cream, a topical treatment for atopic dermatitis and plaque psoriasis; and allergen immunotherapy tablets comprising CEDARCURE and MITICURE. It markets its products primarily through medical representatives for medical professionals. The company has a collaboration with ALK-Abelló A/S to develop and commercializes ALK’s allergen immunotherapy drug targeting pollen diseases caused by grass pollen. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.
Compare 4551 to Peers and Sector
Metrics to compare | 4551 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4551PeersSector | |
|---|---|---|---|---|
P/E Ratio | 31.9x | 12.1x | −0.5x | |
PEG Ratio | 6.28 | 0.13 | 0.00 | |
Price/Book | 1.5x | 1.1x | 2.6x | |
Price / LTM Sales | 2.9x | 1.5x | 3.2x | |
Upside (Analyst Target) | −33.5% | 7.9% | 42.7% | |
Fair Value Upside | Unlock | 8.9% | 5.8% | Unlock |
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 4,200.0
(-33.65% Downside)
Earnings
Latest Release
Apr 25, 2025
EPS / Forecast
49.51 / --
Revenue / Forecast
14.68B / --
People Also Watch
FAQ
What Stock Exchange Does Torii Pharmaceutical Trade On?
Torii Pharmaceutical is listed and trades on the Tokyo Stock Exchange stock exchange.
What Is the Stock Symbol for Torii Pharmaceutical?
The stock symbol for Torii Pharmaceutical is "4551."
What Is the Torii Pharmaceutical Market Cap?
As of today, Torii Pharmaceutical market cap is 177.70B.
What Is Torii Pharmaceutical's Earnings Per Share (TTM)?
The Torii Pharmaceutical EPS (TTM) is 197.61.
When Is the Next Torii Pharmaceutical Earnings Date?
Torii Pharmaceutical will release its next earnings report on 30 Jul 2025.
From a Technical Analysis Perspective, Is 4551 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Torii Pharmaceutical Stock Split?
Torii Pharmaceutical has split 1 times.
How Many Employees Does Torii Pharmaceutical Have?
Torii Pharmaceutical has 592 employees.
What is the current trading status of Torii Pharmaceutical (4551)?
As of 22 Jul 2025, Torii Pharmaceutical (4551) is trading at a price of 6,330.00, with a previous close of 6,320.00. The stock has fluctuated within a day range of 6,320.00 to 6,330.00, while its 52-week range spans from 3,105.00 to 6,420.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.